Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phorone SCHEMBL157728 | 0.82 | LMNA (0.39) | ALDH1A1TSHR | |
| Phorone SCHEMBL23856063 | 0.82 | LMNA (0.39) | ALDH1A1TSHR | |
| SCHEMBL27660912 | 0.79 | — | — | |
| Phorone SCHEMBL27801489 | 0.78 | LMNA (0.36) | ALDH1A1TSHR | |
| Phorone SCHEMBL32672539 | 0.78 | LMNA (0.36) | ALDH1A1TSHR | |
| Phorone SCHEMBL30396963 | 0.78 | LMNA (0.36) | ALDH1A1TSHR | |
| Phorone SCHEMBL28899536 | 0.78 | LMNA (0.36) | ALDH1A1TSHR | |
| Phorone SCHEMBL5084762 | 0.78 | LMNA (0.36) | ALDH1A1TSHR | |
| SCHEMBL29634817 | 0.76 | ALDH1A1 (0.43) | ALDH1A1TSHR | |
| SCHEMBL2133996 | 0.76 | ALDH1A1 (0.43) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4217362-B1 | REDUCTION BY A SILANE IN THE PRESENCE OF ZINC CATALYST | FIRMENICH & CIE (CH) | 2026-03-18 | — | — | EP | claimed |
| US-20240010585-A1 | REDUCTION BY A SILANE IN THE PRESENCE OF ZINC CATALYST | FIRMENICH SA (CH) | 2024-01-11 | — | — | US | claimed |
| EP-4217362-A1 | REDUCTION BY A SILANE IN THE PRESENCE OF ZINC CATALYST | Firmenich SA (CH) | 2023-08-02 | — | — | EP | claimed |
| WO-2022112118-A1 | REDUCTION BY A SILANE IN THE PRESENCE OF ZINC CATALYST | FIRMENICH SA (CH) | 2022-06-02 | — | — | WO | claimed |
| EP-4217362-B1 | REDUCTION BY A SILANE IN THE PRESENCE OF ZINC CATALYST | FIRMENICH & CIE (CH) | 2026-03-18 | — | — | EP | disclosed |
| US-20240010585-A1 | REDUCTION BY A SILANE IN THE PRESENCE OF ZINC CATALYST | FIRMENICH SA (CH) | 2024-01-11 | — | — | US | disclosed |
| EP-4217362-A1 | REDUCTION BY A SILANE IN THE PRESENCE OF ZINC CATALYST | Firmenich SA (CH) | 2023-08-02 | — | — | EP | disclosed |
| WO-2022112118-A1 | REDUCTION BY A SILANE IN THE PRESENCE OF ZINC CATALYST | FIRMENICH SA (CH) | 2022-06-02 | — | — | WO | disclosed |
| CN-109970553-A | A method of preparing 2,3,5- trimethylhydroquinone diester | 万华化学集团股份有限公司 | 2019-07-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240010585-A1 | REDUCTION BY A SILANE IN THE PRESENCE OF ZINC CATALYST | HDAC10, AKR1B10, ADH1A | ALDH1A1 54/4885TSHR 4275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.